Published in Hepatitis Weekly, March 24th, 1997
Hepatitis C virus (HCV) is currently the most common cause of post-transfusion and sporadic non-A/non-B hepatitis (NANBH). The introduction of clotting factor concentrates in the 1970s was largely responsible for the transmission of HCV in hemophiliacs. It has been estimated that between 49 and 100 percent of hemophiliacs who received non-virus-inactivated concentrates show evidence of HCV antibodies.
"In French hemophiliacs who have been transfused repeatedly, anti-HCV antibodies are detected in 69.6...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.